Clinical Trial Update: Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating Zebutinib in combination with immunochemotherapy for newly treated chronic lymphocytic leukemia patients without 17p-/TP53 mutatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Zebutinib

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: UNKNOWN